1. Home
  2. GKOS vs SIGI Comparison

GKOS vs SIGI Comparison

Compare GKOS & SIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$100.96

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Selective Insurance Group Inc.

SIGI

Selective Insurance Group Inc.

HOLD

Current Price

$74.00

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
SIGI
Founded
1998
1926
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
SIGI
Price
$100.96
$74.00
Analyst Decision
Strong Buy
Hold
Analyst Count
14
5
Target Price
$133.07
$84.40
AVG Volume (30 Days)
577.7K
400.6K
Earning Date
04-29-2026
04-22-2026
Dividend Yield
N/A
2.33%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.34
$5.00
Revenue Next Year
$27.46
$4.87
P/E Ratio
N/A
$11.38
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$71.75
52 Week High
$130.23
$93.38

Technical Indicators

Market Signals
Indicator
GKOS
SIGI
Relative Strength Index (RSI) 37.84 22.95
Support Level $94.92 $72.60
Resistance Level $104.66 $80.39
Average True Range (ATR) 4.02 1.59
MACD -0.71 -0.56
Stochastic Oscillator 22.45 10.79

Price Performance

Historical Comparison
GKOS
SIGI

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SIGI Selective Insurance Group Inc.

Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.

Share on Social Networks: